Literature DB >> 8198944

Symptomatic, nonruptured abdominal aortic aneurysms: are emergent operations necessary?

R A Cambria1, P Gloviczki, A W Stanson, K J Cherry, J W Hallett, T C Bower, P C Pairolero.   

Abstract

To evaluate current morbidity and mortality and to define the best strategy of management, we retrospectively reviewed the clinical histories of 36 patients (24 males and 12 females) who underwent repair of symptomatic, nonruptured abdominal aortic aneurysms (AAAs) between April 1, 1987, and April 30, 1992, at the Mayo Clinic (3.2% of 1111 patients with AAA repair). Ages ranged from 54 to 94 years (mean 75 years). All patients were hemodynamically stable and presented with abdominal and/or back pain of 1 to 60 days' duration (mean 11.6 days). The diagnosis of AAA was confirmed by CT scan in 26 patients, ultrasonogram in seven, and plain abdominal films in three. Fourteen patients (38.9%) were operated on emergently within 4 hours of admission, 11 (30.5%) between 4 and 24 hours, and 11 between 24 hours and 7 days following presentation (mean 28.9 hours). Eight (22.2%) had inflammatory aneurysm. AAAs were repaired with a straight graft in 17 patients and a bifurcated graft in 19. Complications occurred in 24 patients (66.7%). Mortality was 11.1% (4/36). The association between emergency repair (< 4 hours) and 60-day mortality was significant (p < 0.05). There were no deaths among those patients whose operation was delayed. Comparison to a matched control group of 72 patients who underwent elective AAA repair revealed an increased incidence of inflammatory aneurysm and female gender among our study group. The symptomatic patients had larger aneurysms (6.5 vs. 5.6 cm, p < 0.05) and required more intraoperative transfusions. Intensive care unit and hospital stay was longer in the symptomatic patients (p < 0.001); morbidity was markedly increased (p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8198944     DOI: 10.1007/BF02018859

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  7 in total

1.  Outcomes of symptomatic abdominal aortic aneurysm repair.

Authors:  Randall R De Martino; Brian W Nolan; Philip P Goodney; Catherine K Chang; Andres Schanzer; Robert Cambria; Daniel J Bertges; Jack L Cronenwett
Journal:  J Vasc Surg       Date:  2010-05-14       Impact factor: 4.268

2.  Abdominal aortic aneurysm (AAA): cost-effectiveness of screening, surveillance of intermediate-sized AAA, and management of symptomatic AAA.

Authors:  Marc D Silverstein; Stephen R Pitts; Elliot L Chaikof; David J Ballard
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

3.  Management of symptomatic abdominal aortic aneurysms following emergency computed tomography.

Authors:  Masahiro Matsushita; Teruo Ikezawa; Masayuki Sugimoto; Akihito Idetsu
Journal:  Surg Today       Date:  2013-02-16       Impact factor: 2.549

4.  Outcomes for symptomatic abdominal aortic aneurysms in the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  Peter A Soden; Sara L Zettervall; Klaas H J Ultee; Jeremy D Darling; Dominique B Buck; Chantel N Hile; Allen D Hamdan; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-04-14       Impact factor: 4.268

5.  Rupture signs on computed tomography, treatment, and outcome of abdominal aortic aneurysms.

Authors:  Kim-Nhien Vu; Youri Kaitoukov; Florence Morin-Roy; Claude Kauffmann; Marie-France Giroux; Eric Thérasse; Gilles Soulez; An Tang
Journal:  Insights Imaging       Date:  2014-05-01

6.  Additional value of biomechanical indices based on CTa for rupture risk assessment of abdominal aortic aneurysms.

Authors:  Eva L Leemans; Tineke P Willems; Cornelis H Slump; Maarten J van der Laan; Clark J Zeebregts
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

7.  Risk Factors for Preoperative Anxiety and Depression in Patients Scheduled for Abdominal Aortic Aneurysm Repair.

Authors:  Xiao-Yan Liu; Yu-Kui Ma; Ji-Chun Zhao; Zhou-Peng Wu; Lin Zhang; Li-Hui Liu
Journal:  Chin Med J (Engl)       Date:  2018-08-20       Impact factor: 2.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.